CX Institutional grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 91.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,574 shares of the company’s stock after purchasing an additional 2,668 shares during the quarter. CX Institutional’s holdings in GE HealthCare Technologies were worth $434,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of GEHC. Wynn Capital LLC boosted its holdings in GE HealthCare Technologies by 4.1% in the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after buying an additional 122 shares during the last quarter. Byrne Asset Management LLC increased its position in shares of GE HealthCare Technologies by 0.8% during the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after purchasing an additional 126 shares in the last quarter. WASHINGTON TRUST Co raised its stake in GE HealthCare Technologies by 7.7% in the 1st quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock valued at $168,000 after purchasing an additional 133 shares during the last quarter. Fiduciary Trust Co boosted its holdings in shares of GE HealthCare Technologies by 1.8% during the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after purchasing an additional 133 shares during the last quarter. Finally, Quent Capital LLC grew its position in shares of GE HealthCare Technologies by 21.3% in the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after purchasing an additional 137 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
Wall Street Analyst Weigh In
GEHC has been the topic of a number of recent research reports. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research report on Tuesday. They set a “buy” rating and a $100.00 price target on the stock. Bank of America cut their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Mizuho decreased their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $94.58.
Check Out Our Latest Report on GEHC
Insider Activity
In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at approximately $1,414,377.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the sale, the chief technology officer now owns 67,300 shares in the company, valued at approximately $5,296,510. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The disclosure for this sale can be found here. In the last three months, insiders sold 93,232 shares of company stock valued at $7,591,282. Insiders own 0.27% of the company’s stock.
GE HealthCare Technologies Stock Up 1.3 %
Shares of GE HealthCare Technologies stock traded up $1.08 on Friday, reaching $83.40. 1,584,290 shares of the company were exchanged, compared to its average volume of 3,113,350. The stock’s 50 day moving average price is $79.20 and its 200-day moving average price is $82.65. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a market cap of $38.07 billion, a P/E ratio of 24.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same period last year, the firm earned $0.92 earnings per share. GE HealthCare Technologies’s quarterly revenue was up .5% on a year-over-year basis. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.
GE HealthCare Technologies Profile
(Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
link